|
|
 |
|
Viewing report
|
|
|
|
Company Financials: DUSA Pharmaceuticals, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
DUSA Pharmaceuticals (DUSA) is an integrated dermatology pharmaceutical company focused on the development and marketing of its Levulan Photodynamic therapy technology platform, a treatment for the pre-cancerous skin lesions known as Actinic Keratoses and complementary dermatology products.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the five company over the last years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Watson Pharmaceuticals, Inc.
Company Financials: Warner Chilcott Limited
Company Financials: Halozyme Therapeutics, Inc.
Company Financials: Basilea Pharmaceutica
Company Financials: QLT, Inc.
Company Financials: Inspire Pharmaceuticals
Company Financials: ISTA Pharmaceuticals, Inc.
Company Financials: Jazz Pharmaceuticals, Inc.
Company Financials: Oncogenex Pharmaceuticals, Inc.
Company Financials: Momenta Pharmaceuticals
|
|
|
|
